JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
MCY
Mercury General Corporation
MCY has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MCY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
MCY's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MCY.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
MCY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $74.50 | -14% |
| Current | 7.4x | $86.41 | — |
| Forward | 7.6x | $86.41 | — |
| Fair | 10x | $119 | +37% |
| Expensive | 13x | $152 | +76% |
Historical ranges are pointers, not guarantees.
MCY has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over MCY on the outlook, with more favorable earnings and profitability expectations.
MCY Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect MCY's revenue to grow, but its profitability to weaken.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
MCY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.41 | -1.7% |
| Q3 2026 | $11.61 | +46% |
| Q2 2026 | $16.92 | +140% |
| Q1 2026 | $15.17 | +194% |
| Q4 2025 | $9.77 | +16% |
| Q3 2025 | $7.93 | -21% |
| Q2 2025 | $7.04 | +22% |
| Q1 2025 | $5.16 | +33% |
| Q4 2024 | $8.45 | +386% |
MCY earned $11.61 per share over the past year, up 46% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MCY on profitability, with a higher operating margin.
MCY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | -13% |
| Q2 2026 | $1.7B | +14% |
| Q1 2026 | $1.5B | +10% |
| Q4 2025 | $1.5B | +12% |
| Q3 2025 | $1.6B | +3.6% |
| Q2 2025 | $1.5B | +13% |
| Q1 2025 | $1.4B | +9.4% |
| Q4 2024 | $1.4B | -0.6% |
MCY's revenue is growing: $1.4B last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.7% | -24 points |
| Q2 2026 | 19% | +5.5 points |
| Q1 2026 | 15% | +26 points |
| Q4 2025 | 16% | +7.2 points |
| Q3 2025 | 22% | +3.3 points |
| Q2 2025 | 14% | +8.2 points |
| Q1 2025 | -10% | -17 points |
| Q4 2024 | 9% | -8.3 points |
MCY's operating margin was −1.7% last quarter, down 24 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MCY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $372.6M | -22% |
| Q2 2026 | $201.6M | -44% |
| Q1 2026 | $308.8M | +$390.7M |
| Q4 2025 | $273.9M | +16% |
| Q3 2025 | $479.5M | +57% |
| Q2 2025 | $357.2M | +34% |
| Q1 2025 | -$81.9M | -145% |
| Q4 2024 | $236M | +9.5% |
MCY has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over MCY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MCY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | +18K shares |
| 5 years | 0% | +14K shares |
| Available history | +0.1% | +29K shares |
MCY has 55M diluted shares, about the same as a year ago.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
MCY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.1x | Net Cash |
| Q1 2025 | -3.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
MCY has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MCY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 19.1 | Oversold |
MCY's weekly RSI is 34 (neutral) and its Stochastic is 19 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
MCY PE vs Financial Services Sector
| Metric | MCY | Sector median | Relative |
|---|---|---|---|
| PE | 7.4x | 13x | 43% below |
| PE % | 32 | 63 | 31 pts below |
MCY has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over MCY on trend strength, trading above more of its moving averages.
MCY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $97.7 | 12% below |
| 20 week MA | $102.7 | 16% below |
| 50 week MA | $97.3 | 11% below |
| 100 week MA | $81.9 | 5.5% above |
| 200 week MA | $63.2 | 37% above |
MCY has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over MCY on returns for 2026, with the stronger performance.
MCY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.6 | $51.8 | +6.6% |
| 2021 | $51.8 | $51.2 | -1.2% |
| 2022 | $51.2 | $33.5 | -35% |
| 2023 | $33.5 | $37.3 | +12% |
| 2024 | $37.3 | $67.0 | +80% |
| 2025 | $67.0 | $94.0 | +40% |
| 2026 YTD | $94.0 | $86.4 | -8% |
MCY has finished higher in four of the last six years. It's down 8% so far in 2026.